No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Nirsevimab prevents hospitalizations due to respiratory syncytial virus (RSV) in infants compared to standard care

byMinjee Kim

December 29, 2023

in StudyGraphics

Reading Time: 1 min read

Click here to read this study in NEJM.

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Shionogi and UBE: Novel Antiviral Drug Demonstrates Efficacy in RSV Patients

Ziresovir reduces the severity of respiratory syncytial virus in hospitalized infants

#VisualAbstract: Ziresovir Reduces Signs and Symptoms in Hospitalized Infants with Respiratory Syncytial Virus Infection

#VisualAbstract: Atezolizumab Monotherapy vs Chemotherapy In Advanced Urothelial Carcinoma

RelatedReports

RSV positivity associated with reduced serious bacterial infection risk [Classics Series]

Pharma

Shionogi and UBE: Novel Antiviral Drug Demonstrates Efficacy in RSV Patients

February 24, 2025

Clinical practice guidelines linked to improved bronchiolitis outcomes

Infectious Disease

Ziresovir reduces the severity of respiratory syncytial virus in hospitalized infants

October 11, 2024

StudyGraphics

#VisualAbstract: Ziresovir Reduces Signs and Symptoms in Hospitalized Infants with Respiratory Syncytial Virus Infection

October 7, 2024

StudyGraphics

#VisualAbstract: Nirsevimab Reduces Hospitalization for RSV Bronchiolitis

July 22, 2024

Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source

Certain genetic predispositions may increase risk of atrial fibrillation among those with high alcohol consumption

Profiling levels of cognitive functioning at 6 months following traumatic brain injury

Patisiran therapy reduces ventricular myocardial strain in hereditary transthyretin amyloidosis

Tafamidis attenuates the decline of cardiac function in patients with transthyretin amyloid cardiomyopathy

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result